Sabbagh Quentin, Ruiz-Pallares Nathalie, Rastin Cassandra, Puechberty Jacques, Guignard Thomas, Jeandel Claire, Merklen Fanny, Pujol Pascal, Kerkhof Jennifer, Sadikovic Bekim, Barat-Houari Mouna, Geneviève David
Department of Clinical Genetics, Centre de Référence « Anomalies du Développement et Syndromes Malformatifs », University Hospital of Montpellier, Inserm UMR1183, Montpellier University, Montpellier, France.
French Society for Predictive and Personalized Medicine (SFMPP), Montpellier, France.
Clin Epigenetics. 2025 Apr 29;17(1):69. doi: 10.1186/s13148-025-01879-z.
Kabuki syndrome type 1 (KS1) is a monogenic disorder arising from pathogenic variants within KMT2D and characterized by syndromic neurodevelopmental delay. We report the retrospective identification of a causative AluY insertion within KMT2D in a genetically unsolved individual with typical KS1 features, after identification of a DNA methylation signature. This is the first documentation of Alu insertion as a molecular mechanism responsible for KS1. This study emphasizes the need for reanalyzing inconclusive sequencing data in individuals with gene-specific phenotypes and reinforces episignature as a reliable diagnostic tool when NGS approaches fail to provide conclusive results in individuals with rare diseases.
1型歌舞伎综合征(KS1)是一种由KMT2D基因内的致病变异引起的单基因疾病,其特征为综合征性神经发育迟缓。在识别出一种DNA甲基化特征后,我们报告了对一名具有典型KS1特征但基因诊断未明确的个体进行回顾性研究,发现其KMT2D基因内存在一个致病性AluY插入。这是首次记录Alu插入作为KS1的分子机制。本研究强调了对具有特定基因表型的个体重新分析不确定测序数据的必要性,并强化了表观遗传学特征作为一种可靠诊断工具的作用,当二代测序方法无法为罕见病个体提供确定性结果时。